In today’s world, drug resistant infections travel and spread as quickly as planes do. Therefore it is in the UK’s interest to tackle AMR and to help other countries to do the same. Priority actions including investing in Universal Health Care and resilient health systems in developing countries, tackling counterfeit drugs and also antibiotic use within animal health and agricultural. This is an issue the UK has an opportunity to be a global leader on, to foster the critical international partnerships between governments, the private sector and civil society that will be necessary to solve the AMR crisis long-term.
